Preventing Recurrent Gestational Diabetes With Metformin
Status:
Unknown status
Trial end date:
2019-09-30
Target enrollment:
Participant gender:
Summary
Study Hypothesis: Intervention with metformin therapy early in pregnancy will prevent
gestational diabetes mellitus recurring in previously affected pregnancies.
Phase:
Phase 4
Details
Lead Sponsor:
Imperial College London
Collaborators:
Imperial College Healthcare NHS Trust London North West Healthcare NHS Trust The Novo Nordisk UK Research Foundation